Piletimasin
Piletimasin is a synthetic analog of the natural product pilocarpine, which is derived from the leaves of the pilocarpus jaborandi plant. It is a muscarinic acetylcholine receptor agonist, primarily used in the treatment of dry eye syndrome. Piletimasin works by stimulating the parasympathetic nervous system, which leads to increased tear production and improved lubrication of the eyes.
The drug was first synthesized in the 1980s and has since been studied for its potential therapeutic
Piletimasin is not approved for use in all countries, and its availability may vary depending on regulatory